June 28, 2017 - By Darrin Black
Oldfield Partners Llp increased General Motors Co (TLK) stake by 92.75% reported in 2016Q4 SEC filing. Oldfield Partners Llp acquired 602,119 shares as General Motors Co (TLK)’s stock rose 18.87%. The Oldfield Partners Llp holds 1.25M shares with $36.49 million value, up from 649,219 last quarter. General Motors Co now has $34.15B valuation. The stock decreased 0.80% or $0.27 during the last trading session, reaching $33.67. About shares traded. Telekomunikasi Indones (Prsr)Tbk PT-ADR (NYSE:TLK) has risen 27.32% since June 28, 2016 and is uptrending. It has outperformed by 10.62% the S&P500.
BioTime, Inc. is a clinical-stage biotechnology firm focused on developing and commercializing products addressing degenerative diseases. The company has market cap of $333.99 million. The Company’s clinical programs are based on two platform technologies: pluripotent stem cells and cell/drug delivery platform technologies. It has a 3.17 P/E ratio. The foundation of its cell delivery platform is its HyStem cell and drug delivery matrix technology.
Since January 1, 0001, it had 2 buys, and 0 insider sales for $6.01 million activity.
It closed at $3.09 lastly. It is down 22.71% since June 28, 2016 and is uptrending. It has outperformed by 6.01% the S&P500.
Broadwood Capital Inc holds 15.24% of its portfolio in BioTime, Inc. for 24.90 million shares. Manatuck Hill Partners Llc owns 730,350 shares or 1.29% of their US portfolio. Moreover, Family Management Corp has 0.28% invested in the company for 115,000 shares. The Massachusetts-based Granite Point Capital Management L.P. has invested 0.23% in the stock. Destination Wealth Management, a California-based fund reported 591,245 shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.